Free Trial
NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Price, News & Analysis

Trinity Biotech logo
$1.13 +0.07 (+6.60%)
Closing price 04:00 PM Eastern
Extended Trading
$1.14 +0.01 (+0.53%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Trinity Biotech Stock (NASDAQ:TRIB)

Advanced

Key Stats

Today's Range
$1.06
$1.17
50-Day Range
$1.02
$9.55
52-Week Range
$0.48
$3.44
Volume
795,057 shs
Average Volume
N/A
Market Capitalization
$4.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Trinity Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

TRIB MarketRank™: 

Trinity Biotech scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Trinity Biotech are expected to grow in the coming year, from ($1.51) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Trinity Biotech is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Trinity Biotech is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Trinity Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    0.66% of the float of Trinity Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Trinity Biotech has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trinity Biotech has recently decreased by 56.88%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Trinity Biotech does not currently pay a dividend.

  • Dividend Growth

    Trinity Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.66% of the float of Trinity Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Trinity Biotech has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trinity Biotech has recently decreased by 56.88%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Trinity Biotech this week, compared to 1 article on an average week.
  • MarketBeat Follows

    Only 2 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Trinity Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.20% of the stock of Trinity Biotech is held by insiders.

  • Percentage Held by Institutions

    78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Trinity Biotech's insider trading history.
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRIB Stock News Headlines

Trinity Biotech Releases 2024 Annual Report
Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
See More Headlines

TRIB Stock Analysis - Frequently Asked Questions

Trinity Biotech's stock was trading at $4.4010 on January 1st, 2025. Since then, TRIB shares have decreased by 74.3% and is now trading at $1.13.

Trinity Biotech PLC (NASDAQ:TRIB) released its quarterly earnings results on Monday, May, 24th. The company reported $2.50 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.75. The company had revenue of $25.59 million for the quarter.
Read the conference call transcript
.

Trinity Biotech shares reverse split on the morning of Wednesday, February 21st 2024.The 1-5 reverse split was announced on Wednesday, February 21st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trinity Biotech investors own include Bristol Myers Squibb (BMY), Micron Technology (MU), OPKO Health (OPK), Novavax (NVAX), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD) and Pfizer (PFE).

Company Calendar

Last Earnings
5/24/2021
Today
10/09/2025
Next Earnings (Estimated)
11/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRIB
CIK
888721
Employees
480
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($14.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.79 million
Net Margins
-68.48%
Pretax Margin
-66.65%
Return on Equity
N/A
Return on Assets
-32.33%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.17
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$61.56 million
Price / Sales
0.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($9.79) per share
Price / Book
-0.12

Miscellaneous

Outstanding Shares
3,592,000
Free Float
3,297,000
Market Cap
$4.13 million
Optionable
Optionable
Beta
N/A

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:TRIB) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners